Kids, prep those arms.
Kids, prep those arms. Moderna announced Wednesday that it is ready to ask the FDA for emergency authorization to begin administering the COVID-19 vaccine to children under 6 years old after testing a lower-dosage shot on about 6,700 participants. Two doses of the 25 µg shot — a quarter of the full dose for adults — was about 44% effective for those 6 months to 2 years and 37.5% effective for those from 2 to 6, according to Moderna. The pediatric doses “showed a robust neutralizing antibody response,” similar to that for adults, the company said. For those who did catch COVID-19 after the shot, the majority of cases were mild, and no severe disease was reported in either group. Both age groups tolerated the shots, primarily reporting “mild to moderate” symptoms.
